Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPREE Knee Sub-study of low-dose aspirin for knee osteoarthritis structural progression
ACTRN12613000754741Phase 3Terminated
- Sponsor
- Monash University
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Low-dose aspirin with Placebo (2 arms). Primary endpoint: Change in knee cartilage volume. Started Jun 2013; status: terminated.
02
Drugs
aspirin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12613000754741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000754741.